Mario Frias
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Mario Frias has a total of 70 co-authors. Here are the top co-authors by number of shared publications:
- Antonio Rivero
Grupo de Virología Clínica y Zoonosis, Unidad de Enfermedades Infecciosas, Instituto Maimónides de Investigación Biomédica de Córdoba (IMIBIC), Hospital Universitario Reina Sofía Universidad de Córdoba Córdoba Spain
4 shared publications - Pedro Lopez-Lopez
Unit of Infectious Diseases, Hospital Universitario Reina Sofia, Clinical Virology and Zoonoses, Instituto Maimonides de Investigación Biomédica de Córdoba (IMIBIC), Universidad de Córdoba (UCO), 14004 Cordoba, Spain
3 shared publications - Angela Camacho
Hospital Reina Sofia, Córdoba, Spain
2 shared publications - David Cano-Terriza
Departamento de Sanidad Animal, Grupo de Investigación en Sanidad Animal y Zoonosis (GISAZ), UIC Zoonosis y Enfermedades Emergentes ENZOEM, Universidad de Córdoba, 14014 Córdoba, Spain
2 shared publications - Francisco Ruiz-Fons
Instituto de Investigación en Recursos Cinegéticos (IREC), CSIC-UCLM-JCCM, Ciudad Real, Spain
2 shared publications - Ignacio García-Bocanegra
Departamento de Sanidad Animal, Grupo de Investigación en Sanidad Animal y Zoonosis (GISAZ), UIC Zoonosis y Enfermedades Emergentes ENZOEM, Universidad de Córdoba, 14014 Córdoba, Spain
2 shared publications
Latest Publications
- Open Access
- 23 April 2026
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 13, 1792421
Serosurvey of Crimean-Congo Hemorrhagic Fever Virus in dromedary camels (Camelus dromedarius) in Egypt
Crimean-Congo hemorrhagic fever virus (CCHFV) is recognized as one of the most severe zoonotic viruses, marked by gastrointestinal disturbances and hemorrhagic symptoms in its more severe forms. Transmission occurs mainly through ticks of the genus Hyalomma or through contact with infected animal tissues. A wide range of animals can be asymptomatically infected, and the presence of antibodies against CCHFV in these animals poses a significant risk to individuals who are in close contact with livestock. Globally, research on CCHFV is scarce, and this is particularly true in the case of Egypt. This study aimed to evaluate the exposure of camels to CCHFV in Egypt and to compare seroprevalence across different geographic regions. In this investigation, a total of 513 serum samples were collected from apparently healthy camels across Egypt, representing the key northern and southern parts of the country, and tested using an enzyme-linked immunosorbent assay (ELISA). Surprisingly, a total of 511 samples (99.61%) tested positive for CCHFV antibodies, representing the highest seroprevalence rate of CCHFV reported at both national and international levels. Seropositivity was consistently observed across all sampled regions. The observed high seroprevalence indicates frequent exposure of camels in Egypt to CCHFV or antigenically related viruses. Camels may therefore represent an important component of viral circulation among livestock populations. Given the close contact between camels and humans during husbandry, transport, and slaughter, these findings support the need for improved surveillance at the camel-human interface. In conclusion, this study provides interesting serological evidence of widespread exposure of camels to CCHFV in Egypt. Further large-scale serological and molecular investigations in livestock and humans, together with the characterization of circulating viral strains and assessment of tick infestation, are required to better define CCHFV transmission dynamics and potential implications for human health.
- 23 April 2026
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 13, 1792421
Open AccessSerosurvey of Crimean-Congo Hemorrhagic Fever Virus in dromedary camels (Camelus dromedarius) in Egypt
Crimean-Congo hemorrhagic fever virus (CCHFV) is recognized as one of the most severe zoonotic viruses, marked by gastrointestinal disturbances and hemorrhagic symptoms in its more severe forms. Transmission occurs mainly through ticks of the genus Hyalomma or through contact with infected animal tissues. A wide range of animals can be asymptomatically infected, and the presence of antibodies against CCHFV in these animals poses a significant risk to individuals who are in close contact with livestock. Globally, research on CCHFV is scarce, and this is particularly true in the case of Egypt. This study aimed to evaluate the exposure of camels to CCHFV in Egypt and to compare seroprevalence across different geographic regions. In this investigation, a total of 513 serum samples were collected from apparently healthy camels across Egypt, representing the key northern and southern parts of the country, and tested using an enzyme-linked immunosorbent assay (ELISA). Surprisingly, a total of 511 samples (99.61%) tested positive for CCHFV antibodies, representing the highest seroprevalence rate of CCHFV reported at both national and international levels. Seropositivity was consistently observed across all sampled regions. The observed high seroprevalence indicates frequent exposure of camels in Egypt to CCHFV or antigenically related viruses. Camels may therefore represent an important component of viral circulation among livestock populations. Given the close contact between camels and humans during husbandry, transport, and slaughter, these findings support the need for improved surveillance at the camel-human interface. In conclusion, this study provides interesting serological evidence of widespread exposure of camels to CCHFV in Egypt. Further large-scale serological and molecular investigations in livestock and humans, together with the characterization of circulating viral strains and assessment of tick infestation, are required to better define CCHFV transmission dynamics and potential implications for human health.
- Open Access
Molecular Characterization and Epidemiology of Anaplasmataceae in Ticks and Domestic Animals in the Colombian Caribbean
Tick-borne diseases (TBD) pose a significant threat to both animal and public health, particularly in tropical regions. In the Colombian Caribbean region, there is limited knowledge of the epidemiology of TBD in domestic animals and their vectors. In this study, conducted in northern Colombia from 2021 to 2022, we analyzed the molecular diversity of Anaplasmataceae in a total of 1156 ticks and blood samples collected from their infested hosts: 56 cattle and 17 equids (horses and mules). Polymerase chain reaction (PCR) assays were performed, using primers to amplify the mitochondrial 16S rRNA gene for tick identification and bacterial 16S and 23S rRNA to detect Anaplasmataceae. The amplified products were sequenced and analyzed for molecular characterization of species. Four tick species were identified: Dermacentor nitens (55.6%), Rhipicephalus microplus (43.0%), Rhipicephalus sanguineus sensu lato (0.7%), and Amblyomma patinoi (0.7%). Overall, 9.4% of the pooled tick samples were identified as R. microplus, and 64.4% of the blood samples tested positive for Anaplasmataceae. Molecular analyses identified Anaplasma marginale in cattle and several species in ticks, including an Anaplasma sp. closely related to A. platys-like, Ehrlichia ruminantium, and E. muris and Ehrlichia variants closely related to Candidatus E. rustica, E. canis, and E. minasensis. The results indicate high infection rates and the circulation of both well-known and potentially novel Anaplasmataceae species, suggesting complex transmission dynamics among ticks and hosts.
Open AccessMolecular Characterization and Epidemiology of Anaplasmataceae in Ticks and Domestic Animals in the Colombian Caribbean
Tick-borne diseases (TBD) pose a significant threat to both animal and public health, particularly in tropical regions. In the Colombian Caribbean region, there is limited knowledge of the epidemiology of TBD in domestic animals and their vectors. In this study, conducted in northern Colombia from 2021 to 2022, we analyzed the molecular diversity of Anaplasmataceae in a total of 1156 ticks and blood samples collected from their infested hosts: 56 cattle and 17 equids (horses and mules). Polymerase chain reaction (PCR) assays were performed, using primers to amplify the mitochondrial 16S rRNA gene for tick identification and bacterial 16S and 23S rRNA to detect Anaplasmataceae. The amplified products were sequenced and analyzed for molecular characterization of species. Four tick species were identified: Dermacentor nitens (55.6%), Rhipicephalus microplus (43.0%), Rhipicephalus sanguineus sensu lato (0.7%), and Amblyomma patinoi (0.7%). Overall, 9.4% of the pooled tick samples were identified as R. microplus, and 64.4% of the blood samples tested positive for Anaplasmataceae. Molecular analyses identified Anaplasma marginale in cattle and several species in ticks, including an Anaplasma sp. closely related to A. platys-like, Ehrlichia ruminantium, and E. muris and Ehrlichia variants closely related to Candidatus E. rustica, E. canis, and E. minasensis. The results indicate high infection rates and the circulation of both well-known and potentially novel Anaplasmataceae species, suggesting complex transmission dynamics among ticks and hosts.
- Open Access
- 20 February 2024
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 134 (8)
The HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers
BACKGROUND: Persistent controllers (PCs) maintain antiretroviral-free HIV-1 control indefinitely over time, while transient controllers (TCs) eventually lose virological control. It is essential to characterize the quality of the HIV reservoir in terms of these phenotypes in order to identify the factors that lead to HIV progression and to open new avenues toward an HIV cure. METHODS: The characterization of HIV-1 reservoir from peripheral blood mononuclear cells was performed using next-generation sequencing techniques, such as full-length individual and matched integration site proviral sequencing (FLIP-Seq; MIP-Seq). RESULTS: PCs and TCs, before losing virological control, presented significantly lower total, intact, and defective proviruses compared with those of participants on antiretroviral therapy (ART). No differences were found in total and defective proviruses between PCs and TCs. However, intact provirus levels were lower in PCs compared with TCs; indeed the intact/defective HIV-DNA ratio was significantly higher in TCs. Clonally expanded intact proviruses were found only in PCs and located in centromeric satellite DNA or zinc-finger genes, both associated with heterochromatin features. In contrast, sampled intact proviruses were located in permissive genic euchromatic positions in TCs. CONCLUSIONS: These results suggest the need for, and can give guidance to, the design of future research to identify a distinct proviral landscape that may be associated with the persistent control of HIV-1 without ART. FUNDING: Instituto de Salud Carlos III (FI17/00186, FI19/00083, MV20/00057, PI18/01532, PI19/01127 and PI22/01796), Gilead Fellowships (GLD22/00147). NIH grants AI155171, AI116228, AI078799, HL134539, DA047034, MH134823, amfAR ARCHE and the Bill and Melinda Gates Foundation.
- 20 February 2024
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 134 (8)
Open AccessThe HIV-1 reservoir landscape in persistent elite controllers and transient elite controllers
BACKGROUND: Persistent controllers (PCs) maintain antiretroviral-free HIV-1 control indefinitely over time, while transient controllers (TCs) eventually lose virological control. It is essential to characterize the quality of the HIV reservoir in terms of these phenotypes in order to identify the factors that lead to HIV progression and to open new avenues toward an HIV cure. METHODS: The characterization of HIV-1 reservoir from peripheral blood mononuclear cells was performed using next-generation sequencing techniques, such as full-length individual and matched integration site proviral sequencing (FLIP-Seq; MIP-Seq). RESULTS: PCs and TCs, before losing virological control, presented significantly lower total, intact, and defective proviruses compared with those of participants on antiretroviral therapy (ART). No differences were found in total and defective proviruses between PCs and TCs. However, intact provirus levels were lower in PCs compared with TCs; indeed the intact/defective HIV-DNA ratio was significantly higher in TCs. Clonally expanded intact proviruses were found only in PCs and located in centromeric satellite DNA or zinc-finger genes, both associated with heterochromatin features. In contrast, sampled intact proviruses were located in permissive genic euchromatic positions in TCs. CONCLUSIONS: These results suggest the need for, and can give guidance to, the design of future research to identify a distinct proviral landscape that may be associated with the persistent control of HIV-1 without ART. FUNDING: Instituto de Salud Carlos III (FI17/00186, FI19/00083, MV20/00057, PI18/01532, PI19/01127 and PI22/01796), Gilead Fellowships (GLD22/00147). NIH grants AI155171, AI116228, AI078799, HL134539, DA047034, MH134823, amfAR ARCHE and the Bill and Melinda Gates Foundation.
- Open Access
- 29 April 2022
- Published by Springer Nature in BMC Zoology
- Vol. 7 (1) , 1-7
Confirmed presence of aedes (rusticoidus) refiki Medschid, 1928 in a continental dry Mediterranean peri-urban environment in south-central Spain
Background: The ‘snow-melt mosquito’ aedes (rusticoidus) refiki is a rare species with a wide distribution in Europe that is usually defined as an aggressive mosquito for mammals, including humans. During a mosquito survey in a peri-urban area in south-central mainland Spain, adult Ae. refiki females were captured and identified by morphological traits. The presence of this species of mosquito has never been molecularly confirmed under continental dry Mediterranean climatic influence with scarce number of days with snow on soil. The aim of this study was to confirm by amplification and sequencing of mitochondrial cytochrome c oxidase subunit I (COI) and internal transcribed spacer 2 (ITS2) region. Results: We also successfully amplified and typed the species molecularly by COI and ITS2 regions. The peri-urban area where Ae. refiki was found contrasts with the reported cold, humid and snowy environments required by the species to breed. Conclusions: This finding suggests that the species is already adapted to continental dry Mediterranean environments, questioning whether it is a truly stenotopic species of cold snowy environments.
- 29 April 2022
- Published by Springer Nature in BMC Zoology
- Vol. 7 (1) , 1-7
Open AccessConfirmed presence of aedes (rusticoidus) refiki Medschid, 1928 in a continental dry Mediterranean peri-urban environment in south-central Spain
Background: The ‘snow-melt mosquito’ aedes (rusticoidus) refiki is a rare species with a wide distribution in Europe that is usually defined as an aggressive mosquito for mammals, including humans. During a mosquito survey in a peri-urban area in south-central mainland Spain, adult Ae. refiki females were captured and identified by morphological traits. The presence of this species of mosquito has never been molecularly confirmed under continental dry Mediterranean climatic influence with scarce number of days with snow on soil. The aim of this study was to confirm by amplification and sequencing of mitochondrial cytochrome c oxidase subunit I (COI) and internal transcribed spacer 2 (ITS2) region. Results: We also successfully amplified and typed the species molecularly by COI and ITS2 regions. The peri-urban area where Ae. refiki was found contrasts with the reported cold, humid and snowy environments required by the species to breed. Conclusions: This finding suggests that the species is already adapted to continental dry Mediterranean environments, questioning whether it is a truly stenotopic species of cold snowy environments.
- Open Access
- 26 April 2022
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 9, 874030
The Common Mosquito (Culex pipiens) Does Not Seem to Be a Competent Vector for Hepatitis E Virus Genotype 3
An experimental infection approach was used to estimate the competence of the common mosquito, Culex pipiens, for hepatitis E virus replication and transmission, using an isolate of hepatitis E virus genotype 3 of human origin in varying infectious doses. The experimental approach was carried out in biosafety level 2 conditions on three batches of 120 Cx. pipiens females, each using an artificial feeding system containing the virus in aliquots of fresh avian blood. Mosquitoes from each batch were collected 1, 7, 14, and 21 days post-infection (dpi) and dissected. The proboscis was subjected to forced excretion of saliva to estimate potential virus transmission. HEV RNA presence in abdomen, thorax, and saliva samples was analyzed by PCR at the selected post-infection times. HEV RNA was detected in the abdomens of Cx. pipiens females collected 1 dpi in the two experimentally-infected batches, but not in the saliva or thorax. None of the samples collected 7–21 dpi were positive. Our results show that Cx. pipiens is not a competent vector for HEV, at least for zoonotic genotype 3.
- 26 April 2022
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 9, 874030
Open AccessThe Common Mosquito (Culex pipiens) Does Not Seem to Be a Competent Vector for Hepatitis E Virus Genotype 3
An experimental infection approach was used to estimate the competence of the common mosquito, Culex pipiens, for hepatitis E virus replication and transmission, using an isolate of hepatitis E virus genotype 3 of human origin in varying infectious doses. The experimental approach was carried out in biosafety level 2 conditions on three batches of 120 Cx. pipiens females, each using an artificial feeding system containing the virus in aliquots of fresh avian blood. Mosquitoes from each batch were collected 1, 7, 14, and 21 days post-infection (dpi) and dissected. The proboscis was subjected to forced excretion of saliva to estimate potential virus transmission. HEV RNA presence in abdomen, thorax, and saliva samples was analyzed by PCR at the selected post-infection times. HEV RNA was detected in the abdomens of Cx. pipiens females collected 1 dpi in the two experimentally-infected batches, but not in the saliva or thorax. None of the samples collected 7–21 dpi were positive. Our results show that Cx. pipiens is not a competent vector for HEV, at least for zoonotic genotype 3.
- Open Access
- 26 December 2019
- Published by MDPI AG in Microorganisms
- Vol. 8 (1) , 51
Ribavirin as a First Treatment Approach for Hepatitis E Virus Infection in Transplant Recipient Patients
The hepatitis E virus (HEV) is the major cause of acute hepatitis of viral origin worldwide. Despite its usual course as an asymptomatic self-limited hepatitis, there are highly susceptible populations, such as those with underlying immunosuppression, which could develop chronic hepatitis. In this situation, implementation of therapy is mandatory in the sense to facilitate viral clearance. Currently, there are no specific drugs approved for HEV infection, but ribavirin (RBV), the drug of choice, is used for off-label treatment. Here, we present two cases of chronic HEV infection in transplant patients, reviewing and discussing the therapeutic approach available in the literature. The use of RBV for the treatment of an HEV infection in organ transplant patients seems to be effective. The recommendation of 12 weeks of therapy is adequate in terms of efficacy. Nevertheless, there are important issues that urgently need to be assessed, such as optimal duration of therapy and drug dosage.
- 26 December 2019
- Published by MDPI AG in Microorganisms
- Vol. 8 (1) , 51
Open AccessRibavirin as a First Treatment Approach for Hepatitis E Virus Infection in Transplant Recipient Patients
The hepatitis E virus (HEV) is the major cause of acute hepatitis of viral origin worldwide. Despite its usual course as an asymptomatic self-limited hepatitis, there are highly susceptible populations, such as those with underlying immunosuppression, which could develop chronic hepatitis. In this situation, implementation of therapy is mandatory in the sense to facilitate viral clearance. Currently, there are no specific drugs approved for HEV infection, but ribavirin (RBV), the drug of choice, is used for off-label treatment. Here, we present two cases of chronic HEV infection in transplant patients, reviewing and discussing the therapeutic approach available in the literature. The use of RBV for the treatment of an HEV infection in organ transplant patients seems to be effective. The recommendation of 12 weeks of therapy is adequate in terms of efficacy. Nevertheless, there are important issues that urgently need to be assessed, such as optimal duration of therapy and drug dosage.
- Open Access
- 26 November 2019
- Published by MDPI AG in Microorganisms
- Vol. 7 (12) , 618
Human Immunodeficiency Virus Infected Patients are Not at Higher Risk for Hepatitis E Virus Infection: A Systematic Review and Meta-Analysis
Hepatitis E virus (HEV) infection is the most common cause of acute hepatitis in the world. It is not well established whether people infected with the human immunodeficiency virus (HIV) are more susceptible to infection with HEV than people not infected with HIV. Many studies have evaluated this relationship, although none are conclusive. The aim of this systematic review and meta-analysis was to assess whether patients with HIV infection constitute a risk group for HEV infection. A systematic review and meta-analysis was performed in line with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), to find publications comparing HEV seroprevalences among HIV infected and uninfected populations. The analysis was matched by sex, age and geographical area, and compared patients who live with HIV and HIV-negative individuals. The odds ratio (OR) for patients with HIV was 0.87 (95% CI: 0.74–1.03) in the fixed effects meta-analysis and 0.88 (95% CI: 0.70–1.11) in random effects, with I2 = 47%. This study did not show that HIV infection was a risk factor for HEV infection when compared with those who are HIV-negative.
- 26 November 2019
- Published by MDPI AG in Microorganisms
- Vol. 7 (12) , 618
Open AccessHuman Immunodeficiency Virus Infected Patients are Not at Higher Risk for Hepatitis E Virus Infection: A Systematic Review and Meta-Analysis
Hepatitis E virus (HEV) infection is the most common cause of acute hepatitis in the world. It is not well established whether people infected with the human immunodeficiency virus (HIV) are more susceptible to infection with HEV than people not infected with HIV. Many studies have evaluated this relationship, although none are conclusive. The aim of this systematic review and meta-analysis was to assess whether patients with HIV infection constitute a risk group for HEV infection. A systematic review and meta-analysis was performed in line with Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), to find publications comparing HEV seroprevalences among HIV infected and uninfected populations. The analysis was matched by sex, age and geographical area, and compared patients who live with HIV and HIV-negative individuals. The odds ratio (OR) for patients with HIV was 0.87 (95% CI: 0.74–1.03) in the fixed effects meta-analysis and 0.88 (95% CI: 0.70–1.11) in random effects, with I2 = 47%. This study did not show that HIV infection was a risk factor for HEV infection when compared with those who are HIV-negative.
- Open Access
- 27 February 2018
- Published by Springer Nature in BMC Veterinary Research
- Vol. 14 (1) , 1-6
Prevalence of hepatitis E virus infection in wild boars from Spain: a possible seasonal pattern?
It has been shown that wildlife can serve as natural reservoirs of hepatitis E virus (HEV). The wild boar (Sus scrofa) is probably the main natural reservoir of HEV and could therefore represent an important route of transmission in Europe, especially in regions where game meat is widely consumed. We evaluated the prevalence of HEV infection in wild boar in the south of Spain, with the aim of identifying associated risk factors. A cross-sectional study that included hunted wild boar was carried out during the 2015/2016 hunting season (October 15 to February 15) in Andalusia (southern Spain). The outcome variable was HEV infection, defined as amplification of HEV RNA in serum by RT-PCR. A total of 142 animals, selected from 12 hunting areas, were included and formed the study population. Thirty-three wild boars (23.2%; 95% CI: 16.8%–30.7%) were positive for HEV infection. Prevalence peaked in October and November, then gradually declined until the end of December. After multivariate analysis, only hunting date was independently associated with HEV infection across sex and age. Our study found a relatively high prevalence of HEV infection in wild boar in the south of Spain, suggesting that prevalence may depend on the season when the animal is hunted. In consequence, the potential risk of zoonotic transmission could fluctuate.
- 27 February 2018
- Published by Springer Nature in BMC Veterinary Research
- Vol. 14 (1) , 1-6
Open AccessPrevalence of hepatitis E virus infection in wild boars from Spain: a possible seasonal pattern?
It has been shown that wildlife can serve as natural reservoirs of hepatitis E virus (HEV). The wild boar (Sus scrofa) is probably the main natural reservoir of HEV and could therefore represent an important route of transmission in Europe, especially in regions where game meat is widely consumed. We evaluated the prevalence of HEV infection in wild boar in the south of Spain, with the aim of identifying associated risk factors. A cross-sectional study that included hunted wild boar was carried out during the 2015/2016 hunting season (October 15 to February 15) in Andalusia (southern Spain). The outcome variable was HEV infection, defined as amplification of HEV RNA in serum by RT-PCR. A total of 142 animals, selected from 12 hunting areas, were included and formed the study population. Thirty-three wild boars (23.2%; 95% CI: 16.8%–30.7%) were positive for HEV infection. Prevalence peaked in October and November, then gradually declined until the end of December. After multivariate analysis, only hunting date was independently associated with HEV infection across sex and age. Our study found a relatively high prevalence of HEV infection in wild boar in the south of Spain, suggesting that prevalence may depend on the season when the animal is hunted. In consequence, the potential risk of zoonotic transmission could fluctuate.